Disclosures for "LACE+ is marginally predictive of 30-day readmission after stroke ")
-
The institution of Dr. Khan has received research support from NINDS. The institution of Dr. Khan has received research support from Genentech. The institution of Dr. Khan has received research support from Spectrum Health-MSU alliance. Dr. Khan has received research support from NIH.
-
Mr. Hildreth has nothing to disclose.
-
Dr. Haggerty has nothing to disclose.
-
Dr. Knight has nothing to disclose.
-
Dr. Miller has nothing to disclose.
-
Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus.
-
Mrs. Scott has nothing to disclose.
-
Tricia Tubergen has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic.
-
Mrs. Evans has nothing to disclose.
-
Dr. Khan has nothing to disclose.
-
Dr. Wees has nothing to disclose.
-
Dr. Ahrar has nothing to disclose.
-
Dr. Min has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott . Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic .
-
Dr. DeJesus Brazitis has nothing to disclose.
-
Laurel Packard has nothing to disclose.